Ipakitine for proven efficacy

Ipakitine was the subject of a comparative study at the Veterinary University of Vienna in 2003 (6). It was aimed at assessing Ipakitine efficacy in reducing phosphataemia and uraemia. It involved both healthy young cats and cats with early stage naturally occurring chronic renal failure.
Ipakitine reduces phosphorus blood concentration

Ipakitine lowers phosphorus absorption in normal cats

Ipakitine lowers phosphataemia in cats with CRF

In cats with CRF, Ipakitine decreases the serum phosphorus concentration from 1.7mmol/l (above the normal range) to 1.1 mmol/l (within the normal range).

Ipakitine reduces uraemia in cats with CRF

Ipakitine shows excellent safety

All other biological parameters (TP, AST, ALT, WBC, RBC, Hk, MCV, MCH ,MCHC)
remained at a normal level and especially blood calcium concentration had not been changing for the 35 days of the trial

(6) Effects of dietary chitosan and calcium carbonate on Ca and P metabolism in cats. E. Wagner, I. Schwendenwein, J. Zentek, BMTW,7/8 (2004)